Vivek Narayan

17PUBLICATIONS

135CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersRadiation therapyCardiology (incl. cardiovascular diseases)Molecular targets

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (17)

Sort by Publication Date:

|May 20, 2026

Cluster Randomized Controlled Trial of Intensive Systolic Blood Pressure Control in Patients With Renal Cell or Thyroid Cancer Receiving VEGFR Tyrosine Kinase Inhibitors: ECOG-ACRIN EAQ191.

|Apr 21, 2026

B7-H3 Gene Expression Shapes Prognosis and Therapeutic Opportunities Across Prostate Cancer Patient Groups.

|Mar 04, 2026

131I-LNTH-1095 Radioligand Therapy plus Enzalutamide versus Enzalutamide Alone in Men with PSMA-Avid Metastatic Castration-Resistant Prostate Cancer: A Phase II Study.

Evan Y Yu, Vivek Narayan, Giuseppe Esposito

|Oct 26, 2025

HLA class I expression shapes the tumor immune microenvironment and influences prognosis in prostate cancer.

Pornlada Likasitwatanakul, Carissa Besonen, Alexander K Tsai

|Aug 12, 2025

Correction: Natural killer cell infiltration in prostate cancers predict improved patient outcomes.

Nicholas A Zorko, Allison Makovec, Andrew Elliott

|Jan 25, 2025

Enhancing Radiation Therapy Response in Prostate Cancer Through Metabolic Modulation by Mito-Lonidamine: A <sup>1</sup>H and <sup>31</sup>P Magnetic Resonance Spectroscopy Study.

Stepan Orlovskiy, Pradeep Kumar Gupta, Fernando Arias-Mendoza

Pageof 3

Frequent Collaborators

5 joint publications

Naomi Balzer-Haas

4 joint publications

Nicholas A Zorko

4 joint publications

Emmanuel S Antonarakis

Allison Makovec

Joseph A Fraietta

Donald L Siegel

Elisabeth I Heath

Eric Jonasch

Shelley L Berger

Gabriela Plesa

Frequent Collaborators

5 joint publications

Naomi Balzer-Haas

4 joint publications

Nicholas A Zorko

4 joint publications

Emmanuel S Antonarakis

3 joint publications

Allison Makovec